Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03849066 · ClinicalTrials.gov registry record
Parent-Reported Symptom Assessments in Children Taking Multiple Medications
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 136
- Enrollment target
NCT03849066: Completed study, sponsored by University of Colorado, Denver.
NCT03849066 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 136 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03849066 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 136 participants
- Enrollment target
Study Summary
This study plans to learn about how to measure symptoms (like tiredness or rash) in children with special healthcare needs who take 5 or more medications. Sometimes symptoms change in severity over time or new symptoms develop. This can happen after a new medication is started. This can also happen after the dose of an existing medication is changed. The Investigators believe that parents will be able to provide the best assessment of any symptoms that their child might be experiencing. This study asks parents to report any symptoms their child is currently experiencing.
Primary Outcome
As the basis for PRSA, we used the PediQuest Memorial Symptom Assessment Scale (PQ-MSAS), which is an adapted pediatric-specific version of the validated adult MSAS that assesses 28 physical and psychological symptoms over the past week. The study instrument is designed to be completed by a full-proxy parent, and 2 versions tailored for specific age groups are available (0-3, 3-18 years-old). Spanish versions are available for both instruments. The PQ-MSAS contains 28 symptom items, each with 4-
Interventions
- OTHER Parent-Reported Symptom Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2022-08-01 |
What the finished NCT03849066 record still lists
NCT03849066 is an observational study that tracks outcomes without assigning an intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Parent-Reported Symptom Assessment is the first listed.
NCT03849066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03849066 about?
NCT03849066 is a clinical study titled "Parent-Reported Symptom Assessments in Children Taking Multiple Medications". This study plans to learn about how to measure symptoms (like tiredness or rash) in children with special healthcare needs who take 5 or more medications. Sometimes symptoms change in severity over time or new symptoms develop. This can happen after a new medication is started. This can also happen ...
What is the current status of trial NCT03849066?
This trial is currently completed. The enrollment target is 136 participants. The study started on 2019-04-01. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT03849066?
The interventions under investigation include: Parent-Reported Symptom Assessment (OTHER).
Who is sponsoring clinical trial NCT03849066?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI